SCHEMBL20439351

SCHEMBL20439351

CC(C)(C)OC(=O)N1CC[C@@H](Oc2ccc(Br)cc2F)C1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.58
PDE4B Q07343 3/20 0.51
USP30 Q70CQ3 3/20 0.51
PIK3CD O00329 4/20 0.48
PIK3CA P42336 2/20 0.48
PIK3CB P42338 2/20 0.48
PIK3CG P48736 2/20 0.48
PDE4D Q08499 3/20 0.47
PDE4A P27815 2/20 0.47
PDE4C Q08493 2/20 0.47
FPR2 P25090 1/20 0.44
PROKR1 Q8TCW9 1/20 0.44
DPP4 P27487 1/20 0.43
TOP2A P11388 1/20 0.42
KDM1A O60341 1/20 0.42
EGFR P00533 1/20 0.42
KDR P35968 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20439353 1.00 GPR119 (0.58) GPR119PDE4BUSP30PIK3CDPIK3CA
SCHEMBL29363719 1.00 GPR119 (0.58) GPR119PDE4BUSP30PIK3CDPIK3CA
SCHEMBL13718678 0.93 GPR119 (0.66) GPR119PDE4BUSP30PDE4DPDE4A
SCHEMBL20425239 0.91 USP30 (0.57) GPR119PDE4BUSP30PDE4D
SCHEMBL22953433 0.88 PDE4B (0.52) GPR119PDE4BUSP30PIK3CDPIK3CA
SCHEMBL13419720 0.87 GPR119 (0.58) GPR119PDE4BUSP30PIK3CDPIK3CA
SCHEMBL29364252 0.87 PDE4B (0.51) GPR119PDE4BUSP30PIK3CDPIK3CA
SCHEMBL28719769 0.87 GPR119 (0.58) GPR119PDE4BUSP30PIK3CDPIK3CA
SCHEMBL30140331 0.87 GPR119 (0.58) GPR119PDE4BUSP30PIK3CDPIK3CA
SCHEMBL26180101 0.87 PDE4B (0.51) GPR119PDE4BUSP30PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018138739-A1 NOVEL ANTIESTROGENIC HETEROCYCLIC COMPOUNDS SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) 2018-08-02 WO disclosed